InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+139.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Breen Michael Martin, Director. Director active across 2 companies, notably GT Biopharma, Inc.. In total, 5 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €113k. Activity tracked since 16 February 2021. The latest transaction was filed on 11 August 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
200,000 shares@ US$0.28769.5% of flowCommon StockSEC:0001493152-23-029061:0
916,112 shares@ US$0.109100.0% of flowCommon StockSEC:0001493152-23-015707:0
Ideal exit: 28 Jan 2024 (T+270)
50,000 shares@ US$0.5030.5% of flowCommon StockSEC:0001493152-23-011888:0
Ideal exit: 6 Jan 2024 (T+270)
278,058 shares0Common StockSEC:0001493152-22-019876:0
278,058 shares0Common StockSEC:0001654954-21-012057:0
5 of 5 declarations
About Breen Michael Martin
Michael Martin Breen is a Board Member of GT Biopharma, Inc. As a member of the board, he participates in the governance of the company and strategic decision-making. Michael brings his expertise and experience to help guide the direction of the company. His role is essential in ensuring compliance and transparency in the operations of GT Biopharma, Inc.
